Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMK1J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,171
Award facts
- Contract value 100% obligated
- $25,171.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $25,171.11 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication on January 9, 2026, with an ultimate completion date of January 12, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s, larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies brand-name and generic medications across multiple therapeutic domains to military and veteran healthcare systems. The company's extensive portfolio of federal contract awards with the DLA demonstrates its capability to efficiently fulfill government procurement requirements for essential pharmaceuticals, including diabetes medications such as Ozempic, specialty treatments, vaccines, and medical supplies. Through its parent organization Cencora, Inc., the company maintains significant contracting relationships with federal agencies including the Department of Defense Health Agency and the U.S. Coast Guard, positioning it as a key supplier within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FMK1J?
SPE2DR26FMK1J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FMK1J worth?
The government has obligated $25,171 on SPE2DR26FMK1J.
Is contract SPE2DR26FMK1J an order under another contract?
Yes. SPE2DR26FMK1J is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMK1J competed?
The extent of competition for SPE2DR26FMK1J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award